On 2025-05-14, Vor Biopharma Inc. (VOR) announced earnings per share of $-0.26 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.25.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.21 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-14 | 2025-03-31 | $-0.25 | $-0.26 |
| 2025-03-20 | 2024-12-31 | $-0.25 | $-0.44 |
| 2024-11-07 | 2024-09-30 | $-0.40 | $-0.40 |
| 2024-08-08 | 2024-06-30 | $-0.41 | $-0.41 |
| 2024-05-09 | 2024-03-31 | $-0.37 | $-0.45 |
| 2024-03-20 | 2023-12-31 | $-0.49 | $-0.39 |
| 2023-11-07 | 2023-09-30 | $-0.46 | $-0.49 |
| 2023-08-10 | 2023-06-30 | $-0.42 | $-0.45 |
| 2023-05-11 | 2023-03-31 | $-0.38 | $-0.43 |
| 2023-03-23 | 2022-12-31 | $-0.56 | $-0.53 |
| 2022-11-10 | 2022-09-30 | $-0.60 | $-0.63 |
| 2022-08-11 | 2022-06-30 | $-0.67 | $-0.58 |
| 2022-05-12 | 2022-03-31 | $-0.54 | $-0.61 |
| 2022-03-14 | 2021-12-31 | $-0.55 | $-0.49 |
| 2021-11-10 | 2021-09-30 | $-0.58 | $-0.50 |
| 2021-08-09 | 2021-06-30 | $-0.47 | $-0.50 |
| 2021-05-06 | 2021-03-31 | $-0.83 | $-0.67 |